pBabe HA-∆Raf1(S642A):ER* puro
(Plasmid
#72572)
-
PurposeExpresses hormone-responsive, feedback-resistant Raf allele with an N-terminal HA tag.
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 72572 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBabe ER* puro
-
Backbone manufacturerMartin McMahon
- Backbone size w/o insert (bp) 6000
- Total vector size (bp) 7200
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameRaf1
-
Alt nameCRAF
-
Alt nameRaf-1
-
Alt namec-Raf
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2037
-
Mutationamino acids 306-648, serine 642 mutated to alanine
-
GenBank IDNM_002880
-
Entrez GeneRAF1 (a.k.a. CMD1NN, CRAF, NS5, Raf-1, c-Raf)
-
Tags
/ Fusion Proteins
- HA (N terminal on insert)
- ER* (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer pBabe 5' (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDeborah Morrison
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBabe HA-∆Raf1(S642A):ER* puro was a gift from Kevin Janes (Addgene plasmid # 72572 ; http://n2t.net/addgene:72572 ; RRID:Addgene_72572) -
For your References section:
Network Architecture Predisposes an Enzyme to Either Pharmacologic or Genetic Targeting. Jensen KJ, Moyer CB, Janes KA. Cell Syst. 2016 Feb 24;2(2):112-121. 10.1016/j.cels.2016.01.012 PubMed 26942229